Business World: Biotechnology & Venture Capital
From The New York Times:
Biotech Tries to Shrug Off Setbacks
By JAMES FLANIGAN
Published: September 17, 2009
"While some investors are pulling back, life sciences companies continue to innovate, and hope the capital to expand will come."
Read the piece
Biotech Tries to Shrug Off Setbacks
By JAMES FLANIGAN
Published: September 17, 2009
"While some investors are pulling back, life sciences companies continue to innovate, and hope the capital to expand will come."
Read the piece
Labels: biotechonology, clinical trials, drug development, industry, pharma, pharmaceutical companies
posted by Anthony Risser at 10:36 AM
0 Comments:
Post a Comment
<< Home